Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation (Q36273309)

13 August 2017

1 reference

title

Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation (English)

1 reference

S-adenosyl-L-homocysteine

13 August 2017

1 reference

chronic renal insufficiency

ChEBI release 2020-05-28

ChEBI ID

16680

1 reference

based on heuristic

inferred from title

S-adenosyl-L-homocysteine

1 reference

1 reference

Coenraad Dirk Adriaan Stehouwer

series ordinal

3

object named as

Coen D A Stehouwer

1 reference

13 August 2017

Coen van Guldener

1

1 reference

PubMed ID

16197293

13 August 2017

Frank Stam

series ordinal

2

1 reference

13 August 2017

1 January 2005

1 reference

Clinical Chemistry and Laboratory Medicine

13 August 2017

1 reference

13 August 2017

43

1 reference

13 August 2017

10

1 reference

13 August 2017

1026-1031

1 reference

Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy

13 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

Local hypomethylation in atherosclerosis found in rabbit ec-sod gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

Plasma protein aspartyl damage is increased in hemodialysis patients: studies on causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

DNA hypomethylation and methyltransferase expression in atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

Creatine supplementation decreases homocysteine in an animal model of uremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.180

Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

Plasma homocysteine is regulated by phospholipid methylation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

Homocysteine and methionine metabolism in ESRD: A stable isotope study.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

The impact of an amino acid-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

Homocysteine metabolism in renal disease

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

Fluctuations in dietary methionine intake do not alter plasma homocysteine concentration in healthy men.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1515/CCLM.2005.180

Identifiers

DOI

10.1515/CCLM.2005.180

1 reference

13 August 2017

1 reference

PubMed ID

16197293